{"id":188860,"date":"2026-02-02T06:00:14","date_gmt":"2026-02-02T06:00:14","guid":{"rendered":"https:\/\/euroupdate.eu\/index.php\/2026\/02\/02\/why-denmark-cant-use-ozempic-as-a-trump-card-with-the-us-in-greenland-talks\/"},"modified":"2026-02-02T06:00:14","modified_gmt":"2026-02-02T06:00:14","slug":"why-denmark-cant-use-ozempic-as-a-trump-card-with-the-us-in-greenland-talks","status":"publish","type":"post","link":"https:\/\/euroupdate.eu\/index.php\/2026\/02\/02\/why-denmark-cant-use-ozempic-as-a-trump-card-with-the-us-in-greenland-talks\/","title":{"rendered":"Why Denmark can&#8217;t use Ozempic as a trump card with the US in Greenland talks"},"content":{"rendered":"<p>Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it&#8217;s not enough to put pressure on US President Donald Trump&#8217;s administration during Greenland talks, experts say. <\/p>\n<p>Read more at <a href=\"http:\/\/www.euronews.com\/health\/2026\/02\/02\/why-denmark-cant-use-ozempic-as-a-trump-card-with-the-us-in-greenland-talks\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it&#8217;s not enough to put pressure on US President Donald Trump&#8217;s administration during Greenland talks, experts say. Read more at Read More<\/p>\n","protected":false},"author":0,"featured_media":188861,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-188860","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-world"],"_links":{"self":[{"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/posts\/188860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/comments?post=188860"}],"version-history":[{"count":0,"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/posts\/188860\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/media\/188861"}],"wp:attachment":[{"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/media?parent=188860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/categories?post=188860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/euroupdate.eu\/index.php\/wp-json\/wp\/v2\/tags?post=188860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}